XML 20 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues        
Total revenues $ 72,211,127 $ 4,846,172 $ 99,417,471 $ 18,313,206
Operating expenses        
Cost of sales and supportive services 3,948,974 83,276 9,551,186 1,330,114
Selling, general and administrative 19,656,138 4,471,640 29,241,565 14,113,384
Research and development 5,732,982 3,235,145 16,119,858 7,801,901
Total operating expenses 29,338,094 7,790,061 54,912,609 23,245,399
Operating income/(loss) 42,873,033 (2,943,889) 44,504,862 (4,932,193)
Gain/(loss) from change in fair value of warrant liability 0 (1,066,522) 400,663 294,548
Other income, net 258,975 26,252 354,670 76,055
Income/(loss) before income taxes 43,132,008 (3,984,159) 45,260,195 (4,561,590)
(Provision)/benefit for income taxes (10,091,420) 870,801 (10,543,595) 805,328
Net and comprehensive income/(loss) $ 33,040,588 $ (3,113,358) $ 34,716,600 $ (3,756,262)
Basic income/(loss) per share (in dollars per share) $ 0.45 $ (0.04) $ 0.48 $ (0.05)
Diluted income/(loss) per share (in dollars per share) $ 0.45 $ (0.04) $ 0.47 $ (0.05)
Weighted average shares outstanding: basic (in shares) 73,024,147 74,840,846 72,924,178 75,822,713
Weighted average shares outstanding: diluted (in shares) 73,259,272 74,840,846 73,616,837 76,634,963
Product Sales and Supportive Services [Member]        
Revenues        
Total revenues $ 65,621,511 $ 2,346,110 $ 81,558,148 $ 12,793,615
Research and Development [Member]        
Revenues        
Total revenues $ 6,589,616 $ 2,500,062 $ 17,859,323 $ 5,519,591